Invention Grant
- Patent Title: Human anti-VEGFR-2/KDR antibodies
-
Application No.: US14431954Application Date: 2013-10-07
-
Publication No.: US10023640B2Publication Date: 2018-07-17
- Inventor: Zhenping Zhu , Dan Lu , Zhanna Polonskaya
- Applicant: Kadmon Corporation, LLC
- Applicant Address: US NY New York
- Assignee: KADMON CORPORATION, LLC
- Current Assignee: KADMON CORPORATION, LLC
- Current Assignee Address: US NY New York
- Agency: Fox Rothschild LLP
- International Application: PCT/US2013/063754 WO 20131007
- International Announcement: WO2014/055998 WO 20140410
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K45/06 ; A61K39/00
Abstract:
The invention relates to antibodies that bind to VEGFR-2. The antibodies are used for treating neoplastic diseases, hyperproliferative disorders, and angiogenic disorders and can be used alone or in combination with other agents.
Public/Granted literature
- US20150284464A1 HUMAN ANTI-VEGFR-2/KDR ANTIBODIES Public/Granted day:2015-10-08
Information query
